Results 161 to 170 of about 945,289 (264)

Association of <i>ADRB2</i> Gene Polymorphisms with Sporting Ability and Human Body Functions: A Literature Review. [PDF]

Genes (Basel)
Li X, Levushkin SP, Kruszewski M, Aksenov MO.   +3 more
europepmc   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

Molecular Oncology, Volume 20, Issue 11, Page 2569-2583, November 2026.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary, Jose Javier Bravo‐Cordero   +1 more
wiley   +1 more source

Effects of three beta adrenergic receptor agonists on growth performance, blood biochemical parameters, fatty acids composition and carnitine palmitoyltransferase I gene expression of rainbow trout, Oncorhynchus mykiss

, 2019
Different beta 1 and 2 adrenergic receptors agonists might have various biological and physiological effects on fish species. An experiment was designed to study the effects of feeding ractopamine, terbutaline and metaproterenol; as beta1, beta2 and less
Yadollahi, F., Jalali, S.
core  

Real‐Time Neurochemical Sensing in Zebrafish: Electrochemical and Fluorescent Approaches

Analysis &Sensing, Volume 6, Issue 6, November 2026.
The use of zebrafish has emerged as a powerful approach for real‐time neurochemical measurements. This review highlights recent advances in electrochemical and fluorescent sensing strategies that enable dynamic measurements in live preparations of this complex vertebrate. These complementary approaches provide new insights into neurochemical signaling,
Piyanka Hettiarachchi, Jacob T. Theismann, Michael A. Johnson   +2 more
wiley   +1 more source

β2-adrenergic receptor stimulation drives differentiation of human adipose-derived mesenchymal stem cells into beige adipocytes. [PDF]

Adipocyte
Maekawa K, Yokoyama F, Tsutsumi R, Tateishi A, Maeda A, Tateishi N.   +5 more
europepmc   +1 more source

Pharmacological Modulation of Catecholaminergic Brain Injury by Dapagliflozin and Its Nanovesicular Formulation in an Isoproterenol Model

Journal of Biochemical and Molecular Toxicology, Volume 40, Issue 11, November 2026.
Bile salt–stabilized nanovesicular dapagliflozin attenuated oxidative stress, neuroinflammation, and neuronal injury while preserving stress‐response proteins and improving behavioral outcomes in an experimental model of isoproterenol‐induced catecholaminergic brain injury.
Faisal Ashraf Bhat, Syed Ehtaishamul Haque, Mohammed Aqil, Mohd Akhtar, Abul Kalam Najmi   +4 more
wiley   +1 more source

Native Mass Spectrometry Reveals Ligand-Specific Conformational Heterogeneity of the β1-Adrenergic Receptor Using Nanobody Probes. [PDF]

Anal Chem
Wang YQ, Lian GT, Chen YA, Chen R, Wu PY, Peng HH, Yen HY.   +6 more
europepmc   +1 more source

Circular RNAs in Drug‐Induced Cardiotoxicity: Roles, Mechanisms, and Therapeutic Potential

Journal of Biochemical and Molecular Toxicology, Volume 40, Issue 11, November 2026.
Circular RNAs have emerged as novel regulators and potential biomarkers in drug‐induced cardiotoxicity. This review summarizes the biogenesis, functional roles, and translational potential of circRNAs in cardiotoxicity assessment and drug safety evaluation.
KeXin Leng, Zixuan Yang, Lei Shi, Zhimin Sun, Mengyun Gu, Naping Tang   +5 more
wiley   +1 more source

Guanfacine as a potential preventive therapy for chronic migraine: a mechanistic hypothesis. [PDF]

Front Neurol
Kesayan T, Patel K.
europepmc   +1 more source

How Can We Personalize the Delivery of Onabotulinumtoxin‐A for Patients With Neurogenic Lower Urinary Tract Dysfunction?

Neurourology and Urodynamics, Volume 45, Issue 8, Page 1500-1506, November 2026.
ABSTRACT Background & Aims Neurogenic lower urinary tract dysfunction (NLUTD) can produce bothersome urinary symptoms, impact quality of life, and in some cases, lead to deterioration of upper urinary tract function. Intradetrusor injection of onabotulinumtoxin‐A (BoNT‐A) is approved for NLUTD in patients who have an inadequate response to or ...
Shirley L. Wang, William I. Jaffe, Ariana L. Smith   +2 more
wiley   +1 more source